Eur J Clin Pharmacol 79(9):123948 Mailhac A, Pedersen L, Pottegrd A, Sndergaard J, Mogensen T, Srensen HT et al (2024) Semaglutide (Ozempic) Use in Denmark 2018 through 2023 - user trends and off-label prescribing for weight loss
Reported observations in clinical trials have included mild to moderate gastrointestinal effects in some participants
Doxorubicin Treatment with L-carnitine may protect heart cells against the toxic side effects of doxorubicin, a medication used to treat cancer, without reducing the effectiveness of this chemotherapy agent
Community sources emphasize watching blood sugar closely, since multiple compounds may compound hypoglycemia risk, and describe blood work (IGF-1, glucose, insulin, HbA1c) as essential
Were also pursuing some truly new mechanisms with the aim of achieving durable weight loss